We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
+0.21%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
+$155M
(+9.5%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
9.43%
Top 10 Holdings %
Top 10 Hldgs %
9.36%
Holding
720
New
123
Increased
315
Reduced
146
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinder Morgan
KMI
|
+$7.76M |
| 2 |
Travelers Companies
TRV
|
+$6.58M |
| 3 |
Helmerich & Payne
HP
|
+$5.67M |
| 4 |
Corning
GLW
|
+$5.46M |
| 5 |
Broadcom
AVGO
|
+$5.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$11.8M |
| 2 |
Accenture
ACN
|
+$10.6M |
| 3 |
PNC Financial Services
PNC
|
+$7.91M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$5.86M |
| 5 |
Yum! Brands
YUM
|
+$5.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.88% |
| 2 | Industrials | 12.82% |
| 3 | Healthcare | 12.23% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Energy | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
MacroGenics
MGNX
$248M
| $1.27M | 0.07% |
33,438
+18,458
| +123% | +$607K |
|
|
GGP
352
DELISTED
GGP Inc.
GGP
| $1.27M | 0.07% |
49,420
+24,953
| +102% | +$696K |
|
|
ESV
353
DELISTED
Ensco Rowan plc
ESV
| $1.26M | 0.07% |
+14,130
| New | +$1.37M |
|
354
Oceaneering
OII
$5.02B
| $1.26M | 0.07% |
+27,000
| New | +$1.42M |
|
355
Eagle Bancorp
EGBN
$865M
| $1.25M | 0.07% |
28,487
-733
| -3% | -$29.2K |
|
356
OSI Systems
OSIS
$3.9B
| $1.25M | 0.07% |
17,670
-860
| -5% | -$62.2K |
|
|
REIS
357
DELISTED
Reis, Inc.
REIS
| $1.25M | 0.07% |
56,282
-1,377
| -2% | -$32.1K |
|
358
Targa Resources
TRGP
$56.4B
| $1.25M | 0.07% |
13,975
+4,973
| +55% | +$485K |
|
|
MRGE
359
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $1.25M | 0.07% |
+259,620
| New | +$1.24M |
|
360
Information Services Group
III
$210M
| $1.24M | 0.07% |
259,575
+122,246
| +89% | +$496K |
|
361
US Physical Therapy
USPH
$1.15B
| $1.24M | 0.07% |
22,651
-576
| -2% | -$28.5K |
|
|
BMTC
362
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.24M | 0.07% |
41,007
-1,058
| -3% | -$31.9K |
|
|
NTRI
363
DELISTED
NutriSystem, Inc.
NTRI
| $1.24M | 0.07% |
49,669
-1,266
| -2% | -$28.4K |
|
364
Qualys
QLYS
$5.67B
| $1.23M | 0.07% |
30,538
-780
| -2% | -$35K |
|
|
PGNX
365
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.22M | 0.07% |
+163,660
| New | +$990K |
|
366
Mondelez International
MDLZ
$79.2B
| $1.22M | 0.07% |
29,638
-353
| -1% | -$13.8K |
|
367
NiSource
NI
$21.3B
| $1.21M | 0.07% |
67,435
+25,463
| +61% | +$453K |
|
368
Escalade
ESCA
$303M
| $1.21M | 0.07% |
65,537
+2,037
| +3% | +$37.3K |
|
369
Enanta Pharmaceuticals
ENTA
$387M
| $1.2M | 0.07% |
26,755
+10,804
| +68% | +$420K |
|
370
Campbell Soup
CPB
$6.79B
| $1.2M | 0.07% |
25,237
-167
| -0.7% | -$7.8K |
|
|
CMRX
371
DELISTED
Chimerix, Inc.
CMRX
| $1.2M | 0.07% |
25,974
-9,606
| -27% | -$385K |
|
|
AUTO
372
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $1.2M | 0.07% |
+74,719
| New | +$1.15M |
|
|
BEAT
373
DELISTED
BioTelemetry, Inc.
BEAT
| $1.19M | 0.07% |
126,489
-3,231
| -2% | -$29.9K |
|
374
Superior Group of Companies
SGC
$218M
| $1.19M | 0.07% |
71,943
+20,707
| +40% | +$390K |
|
|
PRMW
375
DELISTED
Primo Water Corporation
PRMW
| $1.18M | 0.07% |
206,981
-40,888
| -16% | -$235K |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Cadence Capital Management held 720 positions worth $1.79B, up 9.5% from $1.64B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Cadence Capital Management deployed $169M of net new capital in Q2 2015, opening 123 new positions and adding to 315 existing holdings. Its largest new stake was Travelers Companies: 64,242 shares worth $6.21M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Accenture, an estimated $10.6M trimmed.
- Cadence Capital Management's largest Q2 2015 buy was Travelers Companies: 64,242 shares worth $6.21M.
- Cadence Capital Management added most to Kinder Morgan in Q2 2015, an estimated $7.76M increase.
- Cadence Capital Management's biggest Q2 2015 reduction was Accenture, cutting an estimated $10.6M.
- Cadence Capital Management fully exited Freeport-McMoran in Q2 2015, selling an estimated $11.8M.
- Cadence Capital Management's ten largest holdings make up 9.4% of its $1.79B portfolio in Q2 2015.
- Cadence Capital Management opened 123 new positions and closed 117 in Q2 2015.
- Cadence Capital Management's portfolio value rose 9.5% quarter-over-quarter to $1.79B.
Based on Cadence Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.